RENAL SYMPATHETIC DENERVATION FOR TREATMENT OF RESISTANT HYPERTENSION: ONE YEAR RESULTS FROM THE SYMPLICITY HTN-2 RANDOMIZED CONTROLLED TRIAL

被引：7
|
作者：
Esler, Murray D. [1 ]
Krum, Henry [1 ]
Schlaich, Markus [1 ]
Schmieder, Roland [1 ]
Bohm, Michael [1 ]
Sobotka, Paul [1 ]
机构：
[1] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2012年 / 59卷 / 13期
关键词：
D O I：
10.1016/S0735-1097(12)61706-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E1705 / E1705
页数：1
相关论文
共 50 条
  • [1] Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial
    Esler, Murray D.
    Krum, Henry
    Schlaich, Markus
    Schmieder, Roland E.
    Boehm, Michael
    Sobotka, Paul A.
    [J]. CIRCULATION, 2012, 126 (25) : 2976 - 2982
  • [2] Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial
    Fischer Tamas
    [J]. ORVOSI HETILAP, 2014, 155 (21) : 843 - 843
  • [3] RENAL SYMPATHETIC DENERVATION FOR TREATMENT OF RESISTANT HYPERTENSION: TWO-YEAR UPDATE FROM THE SYMPLICITY HTN-2 RANDOMIZED CONTROLLED TRIAL
    Esler, Murray
    Krum, Henry
    Schmieder, Roland
    Bohm, Michael
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1386 - E1386
  • [4] Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
    Esler, Murray D.
    Krum, Henry
    Sobotka, Paul A.
    Schlaich, Markus P.
    Schmieder, Roland E.
    Boehm, Michael
    Mahfoud, Felix
    Sievert, Horst
    Wunderlich, Nina
    Rump, Lars Christian
    Vonend, Oliver
    Uder, Michael
    Lobo, Mel
    Caulfield, Mark
    Erglis, Andrejs
    Azizi, Michel
    Sapoval, Marc
    Thambar, Suku
    Persu, Alexandre
    Renkin, Jean
    Schunkert, Heribert
    Weil, Joachim
    Hoppe, Uta C.
    Walton, Tony
    Scheinert, Dierk
    Binder, Thomas
    Januszewicz, Andrzej
    Witkowski, Adam
    Ruilope, Luis M.
    Whitbourn, Robert
    Bruck, Heike
    Downes, Mark
    Luescher, Thomas F.
    Jardine, Alan G.
    Webster, Mark W.
    Zeller, Thomas
    Sadowski, Jerzy
    Bartus, Krzysztof
    Straley, Craig A.
    Barman, Neil C.
    Lee, David P.
    Witteles, Ronald M.
    Bhalla, Vivek
    Massaro, Joseph M.
    [J]. LANCET, 2010, 376 (9756): : 1903 - 1909
  • [5] One year pooled outcomes following renal sympathetic denervation in patients with resistant hypertension: From the Symplicity HTN-2 trial
    Boehm, M.
    Schlaich, M. P.
    Krum, H.
    Schmieder, R. E.
    Sobotka, P.
    Esler, M. D.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 770 - 770
  • [6] Symplicity HTN-2: International, Multicenter, Prospective, Randomized, Controlled Trial of Endovascular Selective Renal Sympathetic Denervation for the Treatment of Hypertension
    Esler, Murray
    [J]. CIRCULATION, 2010, 122 (21) : 2220 - 2220
  • [7] Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial
    Esler, Murray D.
    Boehm, Michael
    Sievert, Horst
    Rump, Christian L.
    Schmieder, Roland E.
    Krum, Henry
    Mahfoud, Felix
    Schlaich, Markus P.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (26) : 1752 - 1759
  • [8] RENAL SYMPATHETIC DENERVATION FOR TREATMENT OF DRUG-RESISTANT HYPERTENSION IN AN ASIAN POPULATION: RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY IN SOUTH KOREA (GSR KOREA) AND COMPARISON TO SYMPLICITY HTN-2
    Kim, Byeong-Keuk
    Boehm, Michael
    Mahfoud, Felix
    Mancia, Giuseppe
    Park, Sungha
    Hong, Myeong-Ki
    Kim, Hyo-Soo
    Park, Seung-Jung
    Park, Chang Gyu
    Seung, Ki Bae
    Gwon, Hyeon-Cheol
    Choi, Dong-Ju
    Ahn, Tae Hoon
    Kim, Chong Jin
    Kwon, Hyuck Moon
    Esler, Murray
    Jang, Yangsoo
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1521 - A1521
  • [9] Renal sympathetic deverne in resistant HTA: SYMPLICITY HTN-2 study
    Mourad, Jean-Jacques
    [J]. SANG THROMBOSE VAISSEAUX, 2011, 23 (03): : 107 - 108
  • [10] Catheter-based renal sympathetic denervation in patients with resistant hypertension: 18 month follow-up of the Symplicity HTN-2 trial
    Esler, M. D.
    Krum, H.
    Schlaich, M. P.
    Schmieder, R. E.
    Boehm, M.
    Sobotka, P.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 181 - 181
12345